Archives
|
Entry
|
Blogger
|
Date
 ▴
|
Location
|
|
KaloBios Gets $12M Genzyme, Baxter
|
Luke Timmerman |
12/22/08 |
Boston
|
|
Luck, Curiosity, Naivete: The Essential Ingredients of Innovation
|
Luke Timmerman |
12/16/08 |
Seattle
|
|
Economy Makes Disease Foundations Get Choosier
|
Ryan McBride |
12/15/08 |
Boston
|
|
Sequenom May Spot Single-Gene Birth Defects, like Cystic Fibrosis, in a Sample of Mother’s Blood
|
Luke Timmerman |
11/24/08 |
San Diego
|
|
Simple DNA Test Spots Deadly MRSA Bacteria; Adnavance Aims To Take It Mainstream
|
Luke Timmerman |
11/10/08 |
San Diego
|
|
Vertex Cystic Fibrosis Drug Improves Breathing for 28 Days
|
Luke Timmerman |
10/20/08 |
Boston
|
|
Pulmatrix, Emerging From Stealth Mode, Makes Aerosols to Kill Flu and Bacterial Bugs in the Lungs
|
Luke Timmerman |
09/18/08 |
Boston
|
|
Gilead Drug For Cystic Fibrosis Fails to Win FDA Approval
|
Luke Timmerman |
09/16/08 |
Seattle
|
|
Gilead’s Seattle Crew Awaits FDA Clearance of Cystic Fibrosis Drug, Catalyst for Future Growth
|
Luke Timmerman |
09/15/08 |
Seattle
|
|
Alnylam Sees Opportunity in Turning Genes On, And Off
|
Luke Timmerman |
09/05/08 |
Boston
|
|
Vertex Marching Ahead With Cystic Fibrosis Program
|
Luke Timmerman |
08/01/08 |
Boston
|
|
Genzyme, PTC Therapeutics Form Collaboration on Drug For Genetic Diseases
|
Luke Timmerman |
07/17/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.